@article{a7d368a3ff1f419d92d4d2b83d2c789c,
title = "Oncolytic virus immunotherapy",
abstract = "Oncolytic viruses (OVs) were originally developed as direct cytotoxic agents but have been increasingly recognised as a form of immunotherapy [...].",
author = "Antonio Marchini and Ilkow, \{Carolina S.\} and Alan Melcher",
note = "Funding Information: A.M. (Antonio Marchini) is a recipient of research grants from the Luxembourg Cancer Foundation, T?l?vie and the Cooperational Research Program of the German Cancer Research Center (DKFZ), Heidelberg with the Ministry of Science and Technology, Israel. C.S.I (Carolina S. Ilkow) is a recipient of grants from the Canadian Institutes of Health Research (\#377104), BioCanRx, and the Canadian Cancer Society Innovation (\#705973) and Impact (\#IMP-14 and \# 706162) as well as the generous support from the Ontario Institute for Cancer Research, the Ottawa Regional Cancer Foundation and the Ottawa hospital foundation.",
year = "2021",
month = aug,
doi = "10.3390/cancers13153672",
language = "English",
volume = "13",
journal = "Cancers",
issn = "2072-6694",
publisher = "Multidisciplinary Digital Publishing Institute (MDPI)",
number = "15",
}